C57BL/6NCya-Rnf213em1/Cya
Common Name:
Rnf213-KO
Product ID:
S-KO-12190
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Rnf213-KO
Strain ID
KOCMP-672511-Rnf213-B6N-VA
Gene Name
Product ID
S-KO-12190
Gene Alias
6030403J01; D11Ertd759e; mysterin
Background
C57BL/6NCya
NCBI ID
Modification
Conventional knockout
Chromosome
11
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Rnf213em1/Cya mice (Catalog S-KO-12190) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000093902
NCBI RefSeq
NM_001040005
Target Region
Exon 3~66
Size of Effective Region
~75.3 kb
Detailed Document
Overview of Gene Research
Rnf213, also known as Mysterin, is a significant gene with a 591-kDa cytosolic protein product that contains a Walker motif, a RING finger domain, and an RZ finger. It has ATPase and ubiquitin ligase activities and is involved in multiple biological processes such as angiogenesis, lipid metabolism, and immune response [2,4,5]. Rnf213 is strongly associated with moyamoya disease, an uncommon cerebrovascular disorder, and may also be related to other systemic vascular diseases like intracranial artery dissection [1,2,3,6].
In Rnf213-deficient mice and zebrafish, deletion of Rnf213 exacerbated pathological angiogenesis in the cortex and retina [1]. In human brain microvascular endothelial cells, knockdown of Rnf213 led to increased cell proliferation, migration, and tube formation, activating the Hippo pathway effector Yes-associated protein (YAP)/tafazzin (TAZ) and promoting overexpression of the downstream effector VEGFR2 [1].
In conclusion, Rnf213 plays essential roles in angiogenesis and immune-related processes. Research using Rnf213-deficient mouse models has significantly contributed to understanding its role in moyamoya disease, highlighting its importance in the pathogenesis of this cerebrovascular disorder and potentially other related vascular diseases [1].
References:
1. Ye, Fei, Niu, Xingyang, Liang, Feng, Qi, Tiewei, Sheng, Wenli. . RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway. In Brain : a journal of neurology, 146, 4674-4689. doi:10.1093/brain/awad225. https://pubmed.ncbi.nlm.nih.gov/37399508/
2. Fang, Jianxun, Yang, Xinzhuang, Ni, Jun. 2024. RNF213 in moyamoya disease: Genotype-phenotype association and the underlying mechanism. In Chinese medical journal, 137, 2552-2560. doi:10.1097/CM9.0000000000002985. https://pubmed.ncbi.nlm.nih.gov/38243713/
3. Zedde, Marialuisa, Grisendi, Ilaria, Assenza, Federica, Valzania, Franco, Pascarella, Rosario. 2024. RNF213 Polymorphisms in Intracranial Artery Dissection. In Genes, 15, . doi:10.3390/genes15060725. https://pubmed.ncbi.nlm.nih.gov/38927660/
4. Liu, Wanyang, Morito, Daisuke, Takashima, Seiji, Hashimoto, Nobuo, Koizumi, Akio. 2011. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. In PloS one, 6, e22542. doi:10.1371/journal.pone.0022542. https://pubmed.ncbi.nlm.nih.gov/21799892/
5. Pollaci, Giuliana, Gorla, Gemma, Potenza, Antonella, Bersano, Anna, Gatti, Laura. 2022. Novel Multifaceted Roles for RNF213 Protein. In International journal of molecular sciences, 23, . doi:10.3390/ijms23094492. https://pubmed.ncbi.nlm.nih.gov/35562882/
6. Murai, Yasuo, Matano, Fumihiro, Kubota, Asami, Nakae, Ryuta, Tamaki, Tomonori. . RNF213-Related Vasculopathy: Various Systemic Vascular Diseases Involving RNF213 Gene Mutations: Review. In Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 91, 140-145. doi:10.1272/jnms.JNMS.2024_91-215. https://pubmed.ncbi.nlm.nih.gov/38777780/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen